Martial, C., Cassol, H., Charland-Verville, V., Pallavicini, C., Sanz, C., Zamberlan, F., Vivot, R.M., Erowid, F., Erowid, E., Laureys, S., et al. Neurochemical models of near-death experiences: a large-scale study based on the semantic similarity of written reports. Conscious Cogn 69 (2019), 52–69.
Michael, P., Luke, D., Robinson, O., This is your brain on death: a comparative analysis of a near-death experience and subsequent 5-Methoxy-DMT experience. Front Psychol, 14, 2023, 1083361.
Timmermann, C., Roseman, L., Williams, L., Erritzoe, D., Martial, C., Cassol, H., Laureys, S., Nutt, D., Carhart-Harris, R., DMT models the near-death experience. Front Psychol, 9, 2018, 1424.
Jansen, K.L.R., The ketamine model of the near-death experience: a central role for the N-methyl-D-aspartate receptor. J Death Stud 16 (1997), 5–26.
Sweeney, M.M., Nayak, S., Hurwitz, E.S., Mitchell, L.N., Swift, T.C., Griffiths, R.R., Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying. PLoS One, 17, 2022, e0271926 The first large-scale empirical study that compares the effects of experiences on beliefs and attitudes about death, distinguishing between those induced by drugs and those induced by nondrug encounters. The results show significant parallels in reduced fear of death and profound positive effects in both groups. This research highlights the need for future prospective studies of psychedelic administration.
Martial, C., Cassol, H., Laureys, S., Gosseries, O., Near-death experience as a probe to explore (disconnected) consciousness. Trends Cogn Sci 24 (2020), 173–183.
van Lommel, P., van Wees, R., Meyers, V., Elfferich, I., Near-death experience in survivors of cardiac arrest: a prospective study in the Netherlands. Lancet 358 (2001), 2039–2045.
Schwaninger, J., Eisenberg, P.R., Schechtman, K.B., Weiss, A.N., A prospective analysis of near-death experiences in cardiac arrest patients. J Death Stud 20 (2002), 215–232.
Greyson, B., Incidence and correlates of near-death experiences in a cardiac care unit. Gen Hosp Psychiatry 25 (2003), 269–276.
Rousseau, A.-F., Dams, L., Massart, Q., Choquer, L., Cassol, H., Laureys, S., Misset, B., Dardenne, N., Gosseries, O., Martial, C., Incidence of near-death experiences in patients surviving a prolonged critical illness and their long-term impact: a prospective observational study. Crit Care, 27, 2023, 76 One-year prospective study investigating NDEs in a heterogeneous group of intensive care survivors. This study showed a prevalence of NDEs of 15% (out of 126 patients). They also identified spiritual and dissociative propensity as the strongest predictors for the emergence of NDE.
Bush, N.E., Afterward: making meaning after a frightening near-death experience. J Death Stud 21 (2002), 99–133.
Bush, N.E., Greyson, B., Dancing Past the Dark: Distressing Near-death Experiences. 2012, Parson's Porch Books.
Charland-Verville, V., Jourdan, J.-P., Thonnard, M., Ledoux, D., Donneau, A.-F., Quertemont, E., Laureys, S., Near-death experiences in non-life-threatening events and coma of different etiologies. Front Hum Neurosci, 8, 2014, 203.
Bianco, S., Sambin, M., Palmieri, A., Meaning making after a near-death experience: the relevance of intrapsychic and interpersonal dynamics. Death Stud 41 (2017), 562–573.
Bicego, A., Cassol, H., Simon, J., Fritz, P., Abagnale, S., Vanhaudenhuyse, A., Laureys, S., Martial, C., Personality traits and pattern of beliefs of near-death(-like) experiencers. Front Hum Neurosci, 17, 2023, 1124739.
Bianco, S., Testoni, I., Palmieri, A., Solomon, S., Hart, J., The psychological correlates of decreased death anxiety after a near-death experience: the role of self-esteem, mindfulness, and death representations. J Humanist Psychol, 2019, 10.1177/0022167819892107 pp. 2216781989210.
Corazza, O., Schifano, F., Near-death states reported in a sample of 50 misusers. Subst Use Misuse 45 (2010), 916–924.
Strassman, R., DMT: The Spirit Molecule: A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences. 2001, Park Street Press.
Sai-Halasz, A., Brunecker, G., Szara, S., Dimethyltryptamine: a new psycho-active drug. Psychiatr Neurol 135 (1958), 285–301.
Gouzoulis-Mayfrank, E., Heekeren, K., Neukirch, A., Stoll, M., Stock, C., Obradovic, M., Kovar, K.-A., Psychological effects of (S)-ketamine and N,N-Dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. Pharmacopsychiatry 38 (2005), 301–311.
Thonnard, M., Charland-Verville, V., Brédart, S., Dehon, H., Ledoux, D., Laureys, S., Vanhaudenhuyse, A., Characteristics of near-death experiences memories as compared to real and imagined events memories. PLoS One, 8, 2013, e57620.
Strassman, R.J., Qualls, C.R., Uhlenhuth, E.H., Kellner, R., Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry 51 (1994), 98–108.
Michael, P., Luke, D., Robinson, O., An encounter with the other: a thematic and content analysis of DMT experiences from a naturalistic field study. Front Psychol, 12, 2021, 720717.
Martial, C., Fontaine, G., Gosseries, O., Carhart-Harris, R., Timmermann, C., Laureys, S., Cassol, H., Losing the self in near-death experiences: the experience of ego-dissolution. Brain Sci, 11, 2021, 929 The research conducted a survey of 100 individuals who have had NDEs. It discovered that the experience of ego-dissolution, leading to a disturbed sense of self, is a prevalent aspect of NDEs. The study also revealed a positive correlation between the level of intensity of the experience of ego-dissolution and NDE richness factors such as OBE. These findings imply that NDEs offer valuable insights into altered states of consciousness, specifically concerning ego boundaries.
Roseman, L., Nutt, D.J., Carhart-Harris, R.L., Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Front Pharmacol, 8, 2018, 974.
Haijen, E.C.H.M., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R.E., Hampshire, A.D.G., Lorenz, R., et al. Predicting responses to psychedelics: a prospective study. Front Pharmacol, 9, 2018, 897.
Griffiths, R., Richards, W., Johnson, M., McCann, U., Jesse, R., Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J Psychopharmacol 22 (2008), 621–632.
Parnia, S., Spearpoint, K., de Vos, G., Fenwick, P., Goldberg, D., Yang, J., Zhu, J., Baker, K., Killingback, H., McLean, P., et al. AWARE — AWAreness during REsuscitation — a prospective study. Resuscitation 85 (2014), 1799–1805.
Parnia, S., Keshavarz Shirazi, T., Patel, J., Tran, L., Sinha, N., O'Neill, C., Roellke, E., Mengotto, A., Findlay, S., McBrine, M., et al. AWAreness during REsuscitation — II: a multi-center study of consciousness and awareness in cardiac arrest. Resuscitation, 191, 2023, 109903.
Greyson, B., Dissociation in people who have near-death experiences: out of their bodies or out of their minds?. Lancet 355 (2000), 460–463.
Peinkhofer, C., Martial, C., Cassol, H., Laureys, S., Kondziella, D., The evolutionary origin of near-death experiences: a systematic investigation. Brain Commun, 3, 2021, fcab132.
Jansen, K., Using ketamine to induce the near-death experience: mechanism of action and therapeutic potential. Yearbook for Ethnomedicine and the Study of Consciousness, 1996, Wissenschaft und Bildung, 51–81.
Phillips, R., Hazell, L., Sauzet, O., Cornelius, V., Analysis and reporting of adverse events in randomised controlled trials: a review. BMJ Open, 9, 2019, e024537.
McMillan, R., Muthukumaraswamy, S.D., The neurophysiology of ketamine: an integrative review. Rev Neurosci 31 (2020), 457–503.
Carhart-Harris, R.L., Erritzoe, D., Williams, T., Stone, J.M., Reed, L.J., Colasanti, A., Tyacke, R.J., Leech, R., Malizia, A.L., Murphy, K., et al. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci USA 109 (2012), 2138–2143.
Mkrtchian, A., Evans, J.W., Kraus, C., Yuan, P., Kadriu, B., Nugent, A.C., Roiser, J.P., Zarate, C.A., Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals. Mol Psychiatry 26 (2021), 3292–3301.
Martial, C., Cassol, H., Charland-Verville, V., Merckelbach, H., Laureys, S., Fantasy proneness correlates with the intensity of near-death experience. Front Psychiatry, 9, 2018, 190.
Martial, C., Charland-Verville, V., Dehon, H., Laureys, S., False memory susceptibility in coma survivors with and without a near-death experience. Psychol Res 82 (2018), 806–818.
Martial, C., Mensen, A., Charland-Verville, V., Vanhaudenhuyse, A., Rentmeister, D., Bahri, M.A., Cassol, H., Englebert, J., Gosseries, O., Laureys, S., et al. Neurophenomenology of near-death experience memory in hypnotic recall: a within-subject EEG study. Sci Rep, 9, 2019, 14047.
Carhart-Harris, R.L., Friston, K.J., REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacol Rev 71 (2019), 316–344.
Noyes, R., Fenwick, P., Holden, J.M., Sandra Rozan, C., Aftereffects of pleasurable Western adult near-death experiences. The Handbook of Near-death Experiences: Thirty Years of Investigation, 2009, Praeger/ABC-CLIO, 41–62.
Tassell-Matamua, N.A., Lindsay, N., “I'm not afraid to die”: the loss of the fear of death after a near-death experience. Mortality 21 (2016), 71–87.
Griffiths, R.R., Hurwitz, E.S., Davis, A.K., Johnson, M.W., Jesse, R., Survey of subjective “God encounter experiences”: comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. PLoS One, 14, 2019, e0214377.
Groth-Marnat, G., Summers, R., Altered beliefs, attitudes, and behaviors following near-death experiences. J Humanist Psychol 38 (1998), 110–125.
Knoblauch, H., Schmied, I., Schnettler, B., Different kinds of near-death experiences: a report on a survey of near-death experiences in Germany. J Death Stud 20 (2001), 15–29.
Timmermann, C., Kettner, H., Letheby, C., Roseman, L., Rosas, F.E., Carhart-Harris, R.L., Psychedelics alter metaphysical beliefs. Sci Rep, 11, 2021, 22166 This study explores how psychedelic drug use can change long-term beliefs about reality, consciousness, and free will. It shows a shift from materialism to ideas such as pan-psychism and fatalism after using psychedelics, lasting for at least six months and associated with improved mental well-being. Factors such as susceptibility and emotional resonance during the experience matter. An independent clinical trial supports these findings, suggesting that psychedelics can reshape our fundamental worldviews beyond strict materialism.
Simonsson, O., Hendricks, P.S., Chambers, R., Osika, W., Goldberg, S.B., Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics. J Affect Disord 326 (2023), 105–110 This study examines distressing experiences associated with classic psychedelic use in a sample of the US adult population. Approximately 9% (out of 613) of participants who reported lifetime classic psychedelic use reported functional impairment, and 2.6% sought professional help. Factors such as comedication, mindset, and environment were associated with difficulty and risk of harm during these experiences.
Golden, T.L., Magsamen, S., Sandu, C.C., Lin, S., Roebuck, G.M., Shi, K.M., Barrett, F.S., Effects of setting on psychedelic experiences, therapies, and outcomes: a rapid scoping review of the literature. Barrett, F.S., Preller, K.H., (eds.) Disruptive Psychopharmacology, 2022, Springer International Publishing, 35–70.
Johnson, M., Richards, W., Griffiths, R., Human hallucinogen research: guidelines for safety. J Psychopharmacol 22 (2008), 603–620.
Carbonaro, T.M., Bradstreet, M.P., Barrett, F.S., MacLean, K.A., Jesse, R., Johnson, M.W., Griffiths, R.R., Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences. J Psychopharmacol 30 (2016), 1268–1278.
